Single-Dose breast radiation may cut fatigue in half
NCT ID NCT03838419
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares a single dose of radiation given during breast cancer surgery (IORT) to standard whole breast radiation given over weeks. The goal is to see if IORT causes less fatigue in women with low-risk early breast cancer. About 100 women aged 50 and older with small, hormone-sensitive tumors are being enrolled.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- intraoperative radiotherapy (IORT)
- What this could lead to
- If it works, this could offer a shorter, less tiring radiation option for early-stage breast cancer patients.
- What could go wrong
- This trial is suspended, so results may never come. IORT is still experimental for this use, and long-term cancer control data are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital of Heidelberg, Radiation Oncology
Heidelberg, 69120, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?